We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPY icon
3801
Oppenheimer Holdings
OPY
$1.25B
$15K ﹤0.01%
371
+274
+282% +$12K
OTLY
3802
Oatly Group
OTLY
$441M
$15K ﹤0.01%
300
-93
-24% -$4.34K
PBYI icon
3803
Puma Biotechnology
PBYI
$456M
$15K ﹤0.01%
4,853
-9,897
-67% -$37.3K
PGC icon
3804
Peapack-Gladstone Financial
PGC
$828M
$15K ﹤0.01%
509
-408
-44% -$14.5K
POWL icon
3805
Powell Industries
POWL
$7.78B
$15K ﹤0.01%
1,062
+204
+24% +$2.83K
PPC icon
3806
Pilgrim's Pride
PPC
$6.64B
$15K ﹤0.01%
631
-4,595
-88% -$111K
PSET icon
3807
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$29.3M
$15K ﹤0.01%
283
-3
-1% -$155
RRBI icon
3808
Red River Bancshares
RRBI
$676M
$15K ﹤0.01%
320
-65
-17% -$3.22K
SGML icon
3809
Sigma Lithium
SGML
$1.34B
$15K ﹤0.01%
+412
New +$13.2K
SGMO
3810
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$15K ﹤0.01%
8,473
+3,234
+62% +$9.23K
SKYT
3811
DELISTED
SkyWater Technology
SKYT
$15K ﹤0.01%
1,300
+652
+101% +$7.3K
SLDP icon
3812
Solid Power
SLDP
$552M
$15K ﹤0.01%
5,031
-891
-15% -$2.69K
SMFG icon
3813
Sumitomo Mitsui Financial
SMFG
$167B
$15K ﹤0.01%
1,908
-1,213
-39% -$10.3K
SRAD icon
3814
Sportradar
SRAD
$4.09B
$15K ﹤0.01%
+1,282
New +$14.9K
STRO icon
3815
Sutro Biopharma
STRO
$340M
$15K ﹤0.01%
317
+183
+137% +$11.6K
SWBI icon
3816
Smith & Wesson
SWBI
$643M
$15K ﹤0.01%
1,232
-430
-26% -$4.6K
TALK icon
3817
Talkspace
TALK
$871M
$15K ﹤0.01%
21,937
-11,842
-35% -$9.39K
TILE icon
3818
Interface
TILE
$2.19B
$15K ﹤0.01%
1,803
-7,981
-82% -$78.5K
TOST icon
3819
Toast
TOST
$20.1B
$15K ﹤0.01%
842
-7,310
-90% -$144K
TTGT icon
3820
TechTarget
TTGT
$278M
$15K ﹤0.01%
415
+168
+68% +$7.03K
UP icon
3821
Wheels Up
UP
$182M
$15K ﹤0.01%
116
+87
+300% +$19.3K
UPXI icon
3822
Upexi
UPXI
$54.9M
$15K ﹤0.01%
185
-56
-23% -$4.33K
URG
3823
Ur-Energy
URG
$537M
$15K ﹤0.01%
14,003
-10,739
-43% -$12.1K
AD
3824
Array Digital Infrastructure
AD
$3.11B
$15K ﹤0.01%
725
-1,087
-60% -$24.3K
VIGL
3825
DELISTED
Vigil Neuroscience
VIGL
$15K ﹤0.01%
1,482
-350
-19% -$3.94K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.